Stock Events

Stock Events

HBM Limited 

HK$13.54
0
+HK$0.64+4.96% Today

Statistics

Day High
13.68
Day Low
12.92
52W High
17.89
52W Low
7.74
Volume
137,280,000
Avg. Volume
-
Mkt Cap
11.47B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30MarExpected
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
0
0.23
0.47
0.7
Expected EPS
N/A
Actual EPS
N/A

Financials

7.29%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
592.84MRevenue
43.21MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2142.HK. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

HBM Holdings Limited, a clinical-stage biopharmaceutical company, engages in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. It is developing Batoclimab (HBM9161), a human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor; Tanfanercept (HBM9036) to treat moderate to-severe dry eye disease; HBM7008, a bispecific antibody targeting tumor Associated antigen; and HBM4003, a human anti-CTLA-4 antibody against cytotoxic T-lymphocyte-associated antigen-4. The company is also developing HBM9022 for the treatment of SARS-COV-2; HBM9302 for the treatment of breast and gastric cancers; HBM7020 for the treatment of multiple myeloma; and HBM1007, HBM1029, HBM7015, HBM7008, and HBM1022 for the treatment of solid tumors. It operates in Mainland China, the United States, Europe, and internationally. The company has collaboration on antibody-drug conjugate projects with LegoChem Biosciences Inc. and Duality Biotherapeutics, Inc. HBM Holdings Limited was incorporated in 2016 and is based in Shanghai, the People's Republic of China.
Show more...
CEO
Dr. Jingsong Wang M.D., Ph.D.
Employees
396
Country
Hong Kong
ISIN
KYG4403H1002

Listings

MU
DE
6XY.MU
F
DE
6XY.F
OTC Link
US
HBMHF
HK
HK
2142.HK

0 Comments

Share your thoughts

FAQ

What is HBM Limited stock price today?▼
The current price of 2142.HK is HK$13.54 HKD — it has increased by +4.96% in the past 24 hours. Watch HBM Limited stock price performance more closely on the chart.
What is HBM Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange HBM Limited stocks are traded under the ticker 2142.HK.
Is HBM Limited stock price growing?▼
2142.HK stock has risen by +4.07% compared to the previous week, the month change is a -6.43% fall, over the last year HBM Limited has showed a +65.53% increase.
What is HBM Limited market cap?▼
Today HBM Limited has the market capitalization of 11.47B
When is the next HBM Limited earnings date?▼
HBM Limited is going to release the next earnings report on September 02, 2026.
What is HBM Limited revenue for the last year?▼
HBM Limited revenue for the last year amounts to 592.84M HKD.
What is HBM Limited net income for the last year?▼
2142.HK net income for the last year is 43.21M HKD.
How many employees does HBM Limited have?▼
As of May 07, 2026, the company has 396 employees.
In which sector is HBM Limited located?▼
HBM Limited operates in the Health & Wellness sector.
When did HBM Limited complete a stock split?▼
HBM Limited has not had any recent stock splits.
Where is HBM Limited headquartered?▼
HBM Limited is headquartered in Shanghai, Hong Kong.